Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandprotesehuset ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5%   Bankruptcy risk   2.6% 1.8% 2.3% 2.6% 2.1% 1.6% 8.0% 8.0%   Credit score (0-100)   63 73 65 60 67 74 31 31   Credit rating   BBB A BBB BBB A A BB BB   Credit limit (kDKK)   0.0 4.5 0.1 0.0 1.3 76.3 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   12,535 17,311 16,528 21,910 25,453 32,169 0.0 0.0   EBITDA   2,662 4,525 2,211 8,075 7,614 13,286 0.0 0.0   EBIT   1,930 3,168 707 6,426 5,834 10,866 0.0 0.0   Pre-tax profit (PTP)   1,641.3 2,887.5 515.8 6,345.7 5,818.2 11,044.9 0.0 0.0   Net earnings   1,260.0 2,245.4 392.5 4,941.1 4,544.2 8,635.3 0.0 0.0   Pre-tax profit without non-rec. items   1,641 2,887 516 6,346 5,818 11,045 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   6,770 7,024 6,890 7,869 8,392 10,949 0.0 0.0   Shareholders equity total   1,247 3,493 2,185 6,626 8,170 16,806 16,756 16,756   Interest-bearing liabilities   3,204 1,390 472 154 0.0 320 0.0 0.0   Balance sheet total (assets)   8,158 9,387 10,841 14,711 16,907 27,694 16,756 16,756   Net Debt   3,177 1,238 202 -710 -2,017 -7,409 -16,756 -16,756     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   12,535 17,311 16,528 21,910 25,453 32,169 0.0 0.0   Gross profit growth   110.4% 38.1% -4.5% 32.6% 16.2% 26.4% -100.0% 0.0%   Employees   26 32 34 35 36 34 0 0   Employee growth %   100.0% 23.1% 6.3% 2.9% 2.9% -5.6% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   8,158 9,387 10,841 14,711 16,907 27,694 16,756 16,756   Balance sheet change%   109.0% 15.1% 15.5% 35.7% 14.9% 63.8% -39.5% 0.0%   Added value   2,662.1 4,524.9 2,211.3 8,075.3 7,482.7 13,286.1 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   3,204 -1,103 -1,638 -670 -1,257 136 -10,949 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   15.4% 18.3% 4.3% 29.3% 22.9% 33.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   32.0% 36.2% 7.4% 51.4% 37.8% 50.2% 0.0% 0.0%   ROI %   60.4% 59.6% 14.7% 100.8% 66.3% 80.2% 0.0% 0.0%   ROE %   48.9% 94.7% 13.8% 112.2% 61.4% 69.1% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   17.0% 41.6% 24.4% 51.8% 55.1% 65.0% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   119.3% 27.4% 9.1% -8.8% -26.5% -55.8% 0.0% 0.0%   Gearing %   256.9% 39.8% 21.6% 2.3% 0.0% 1.9% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   12.2% 12.5% 25.4% 68.9% 209.5% 96.1% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.2 0.5 0.7 1.5 1.8 2.7 0.0 0.0   Current Ratio   0.2 0.4 0.5 1.0 1.2 2.1 0.0 0.0   Cash and cash equivalent   27.5 152.4 269.8 863.2 2,017.3 7,729.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -5,452.9 -2,991.1 -3,416.9 118.8 1,516.1 8,340.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   102 141 65 231 208 391 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   102 141 65 231 211 391 0 0   EBIT / employee   74 99 21 184 162 320 0 0   Net earnings / employee   48 70 12 141 126 254 0 0